Thrive Partners Vii Growth Gp, Purchases 444,712 Shares of Oscar Health, Inc. (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) major shareholder Thrive Partners Vii Growth Gp, bought 444,712 shares of Oscar Health stock in a transaction that occurred on Thursday, September 9th. The shares were acquired at an average cost of $17.50 per share, for a total transaction of $7,782,460.00. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Thrive Partners Vii Growth Gp, also recently made the following trade(s):

  • On Monday, September 13th, Thrive Partners Vii Growth Gp, purchased 377,552 shares of Oscar Health stock. The stock was purchased at an average cost of $17.24 per share, for a total transaction of $6,508,996.48.
  • On Monday, August 30th, Thrive Partners Vii Growth Gp, purchased 329,885 shares of Oscar Health stock. The stock was purchased at an average cost of $14.78 per share, for a total transaction of $4,875,700.30.
  • On Thursday, August 26th, Thrive Partners Vii Growth Gp, purchased 204,811 shares of Oscar Health stock. The stock was purchased at an average cost of $13.74 per share, for a total transaction of $2,814,103.14.
  • On Tuesday, August 24th, Thrive Partners Vii Growth Gp, purchased 1,074,342 shares of Oscar Health stock. The stock was purchased at an average cost of $12.69 per share, for a total transaction of $13,633,399.98.
  • On Friday, August 20th, Thrive Partners Vii Growth Gp, purchased 68,042 shares of Oscar Health stock. The stock was purchased at an average cost of $13.41 per share, for a total transaction of $912,443.22.

Shares of NYSE OSCR opened at $17.77 on Wednesday. Oscar Health, Inc. has a 1 year low of $12.06 and a 1 year high of $37.00. The company’s 50-day simple moving average is $16.63.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, August 12th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.12. The business had revenue of $529.28 million for the quarter. As a group, equities analysts anticipate that Oscar Health, Inc. will post -2.75 earnings per share for the current year.

A number of equities research analysts have recently weighed in on the stock. Cowen assumed coverage on shares of Oscar Health in a research note on Thursday, September 9th. They set a “market perform” rating and a $15.00 target price on the stock. Wells Fargo & Company cut their target price on shares of Oscar Health from $37.00 to $30.00 and set an “overweight” rating on the stock in a research note on Friday, August 13th. Zacks Investment Research raised shares of Oscar Health from a “sell” rating to a “hold” rating in a research note on Thursday, July 15th. Finally, Morgan Stanley cut their target price on shares of Oscar Health from $44.00 to $26.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 31st. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $31.33.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Advisor Group Holdings Inc. lifted its position in Oscar Health by 155.2% during the 2nd quarter. Advisor Group Holdings Inc. now owns 1,725 shares of the company’s stock valued at $37,000 after acquiring an additional 1,049 shares during the period. First Horizon Advisors Inc. purchased a new position in Oscar Health in the first quarter worth about $33,000. Alyeska Investment Group L.P. raised its holdings in Oscar Health by 0.7% in the second quarter. Alyeska Investment Group L.P. now owns 231,400 shares of the company’s stock worth $4,975,000 after buying an additional 1,500 shares during the last quarter. M&T Bank Corp raised its holdings in Oscar Health by 11.6% in the second quarter. M&T Bank Corp now owns 16,302 shares of the company’s stock worth $351,000 after buying an additional 1,688 shares during the last quarter. Finally, Rockefeller Capital Management L.P. purchased a new position in Oscar Health in the first quarter worth about $76,000. 69.17% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc provides health insurance products and services to individuals, families, and businesses in the United States. The company was formerly known as Mulberry Health Inc and changed its name to Oscar Health, Inc in January 2021. Oscar Health, Inc was founded in 2012 and is headquartered in New York, New York.

Read More: Initial Coin Offerings entail a high degree of risk

Insider Buying and Selling by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.